Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Biodesix Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
1 insider, $1.03M in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$1.03M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Biodesix Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Biodesix Inc
NameTitleLast reported holdingLast filingFilings, past year
Schuler Jack W10% Owner, Other: Emeritus Director555,810IndirectAug 13, 20264
Patience JohnDirector, Other: Chairman25,383Jul 2, 20264
Hutton ScottPresident & CEO48,767Feb 23, 20265
Cowie Robin HarperCFO, Sec'y & Treasurer16,231Feb 23, 20265
Pestano Gary AnthonyChief Development Officer10,359Feb 23, 20265
O'Kane KieranChief Commercial Officer9,819Feb 23, 20265
Vazquez ChrisChief Accounting Officer1,586Feb 23, 20265
Massarany HanyDirector310,135Jan 6, 20261
Kayyem Jon FaizDirector180,085IndirectJan 6, 20261
Strobeck MatthewDirector2,606,879IndirectJan 6, 20261
Franchi Jean M.Director108,140Jan 6, 20261
Kennedy Lawrence T. JrDirector, 10% Owner10,411,024IndirectJan 6, 20261
Watts Charles MDirector421,705Apr 2, 20250
Siurek Ryan HChief Accounting Officer40,268May 10, 20230
Georgantas Robert William IIIChief Scientific Officer38,114Nov 21, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2021 (view filing)Aug 134 daysSchuler Jack WDirector, 10% OwnerPPurchase+232.0K$7.50+$1.74M+4.1%5.96M after
Aug 19, 2021 (view filing)Aug 172 daysPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+1.60K$7.12+$11.4K+0.1%1.91M after
Aug 19, 2021 (view filing)Aug 172 daysSchuler Jack WDirector, 10% OwnerPPurchase+29.4K$7.18+$211.4K+0.5%5.99M after
Aug 23, 2021 (view filing)Aug 194 daysSchuler Jack WDirector, 10% OwnerPPurchase+50.0K$7.69+$384.5K+0.8%6.04M after
Aug 23, 2021 (view filing)Aug 194 daysPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+8.40K$8.04+$67.5K+0.4%1.92M after
Nov 18, 2021 (view filing)Nov 171 dayCowie Robin HarperCFO, Sec'y & TreasurerPPurchase+1.00K$6.51+$6.51K+2.4%42.0K after
Nov 18, 2021 (view filing)Nov 171 dayHutton ScottPresident & CEOPPurchase+3.00K$6.46+$19.4K+44.4%9.76K after
Nov 19, 2021 (view filing)Nov 172 daysSchuler Jack WDirector, 10% OwnerPPurchase+20.0K$6.51+$130.2K+0.3%6.06M after
Nov 22, 2021 (view filing)Nov 184 daysSchuler Jack WDirector, 10% OwnerPPurchase+28.4K$6.33+$179.5K+0.5%6.08M after
Nov 22, 2021 (view filing)Nov 184 daysPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+9.50K$6.34+$60.2K+0.5%1.93M after
Nov 23, 2021 (view filing)Nov 194 daysSchuler Jack WDirector, 10% OwnerPPurchase+60.0K$6.50+$390.0K+1.0%6.14M after
Nov 24, 2021 (view filing)Nov 222 daysSchuler Jack WDirector, 10% OwnerPPurchase+20.0K$6.34+$126.8K+0.3%6.16M after
Nov 24, 2021 (view filing)Nov 231 dayPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+10.0K$6.18+$61.8K+0.5%1.94M after
Dec 22, 2021 (view filing)Dec 202 daysWatts Charles MDirectorPPurchase+5.86K$4.29+$25.1K+292.8%7.86K after
Jan 4, 2022 (view filing)Dec 30, 20215 daysPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+160.9K$4.35+$700.0KNew position53.0K after2 lots
Jan 4, 2022 (view filing)Dec 30, 20215 daysStrobeck MatthewDirectorPPurchase+147.8K$4.35+$642.9KNew position19.9K after2 lots
Jan 31, 2022 (view filing)Dec 30, 202132 daysSchuler Jack WDirector, 10% OwnerPPurchase+2.30M$4.35+$10.0M+37.3%8.46M afterAmended
Apr 11, 2022 (view filing)Apr 74 daysSchuler Jack WDirector, 10% OwnerPPurchase+2.79M$1.79+$5.00M+33.0%11.3M after
Apr 11, 2022 (view filing)Apr 74 daysStrobeck MatthewDirectorPPurchase+558.7K$1.79+$1.00M+56.6%1.55M after
Apr 11, 2022 (view filing)Apr 74 daysStrobeck MatthewDirectorPPurchase+558.7K$1.79+$1.00M+264.5%769.9K after
Apr 11, 2022 (view filing)Apr 74 daysPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+279.3K$1.79+$500.0K+476.7%337.9K after
May 11, 2022 (view filing)May 101 dayCowie Robin HarperCFO, Sec'y & TreasurerSSale−3.34K$1.83−$6.11K−5.4%58.5K after
May 11, 2022 (view filing)May 101 dayPestano Gary AnthonyChief Development OfficerSSale−1.47K$1.83−$2.68K−1.7%85.8K after
May 11, 2022 (view filing)May 101 dayHutton ScottPresident & CEOSSale−13.3K$1.83−$24.3K−23.2%43.9K after
May 11, 2022 (view filing)May 101 dayGeorgantas Robert William IIIChief Scientific OfficerSSale−2.00K$1.83−$3.67K−9.9%18.3K after
May 11, 2022 (view filing)May 101 daySiurek Ryan HChief Accounting OfficerSSale−1.95K$1.83−$3.56K−20.8%7.40K after
May 11, 2022 (view filing)May 101 dayO'Kane KieranChief Commercial OfficerSSale−1.58K$1.83−$2.90K−17.2%7.64K after
Aug 10, 2022 (view filing)Aug 91 dayO'Kane KieranChief Commercial OfficerSSale−1.67K$2.53−$4.23K−12.8%11.4K after
Aug 10, 2022 (view filing)Aug 91 dayPestano Gary AnthonyChief Development OfficerSSale−1.55K$2.53−$3.92K−1.7%89.3K after
Aug 10, 2022 (view filing)Aug 91 dayGeorgantas Robert William IIIChief Scientific OfficerSSale−1.69K$2.53−$4.27K−7.0%22.2K after
Aug 10, 2022 (view filing)Aug 91 daySiurek Ryan HChief Accounting OfficerSSale−1.65K$2.53−$4.16K−12.8%11.2K after
Aug 10, 2022 (view filing)Aug 91 dayCowie Robin HarperCFO, Sec'y & TreasurerSSale−3.53K$2.53−$8.94K−5.0%66.5K after
Aug 10, 2022 (view filing)Aug 91 dayHutton ScottPresident & CEOSSale−13.6K$2.53−$34.5K−15.4%75.0K after
Nov 10, 2022 (view filing)Nov 9-101 daySiurek Ryan HChief Accounting OfficerSSale−1.73K$1.03−$1.78K−10.3%15.0K after2 lots
Nov 10, 2022 (view filing)Nov 9-101 dayPestano Gary AnthonyChief Development OfficerSSale−1.58K$1.03−$1.63K−1.7%92.7K after2 lots
Nov 10, 2022 (view filing)Nov 9-101 dayCowie Robin HarperCFO, Sec'y & TreasurerSSale−3.58K$1.03−$3.69K−4.6%74.5K after2 lots
Nov 10, 2022 (view filing)Nov 9-101 dayHutton ScottPresident & CEOSSale−13.8K$1.03−$14.2K−11.5%106.0K after2 lots
Nov 10, 2022 (view filing)Nov 9-101 dayGeorgantas Robert William IIIChief Scientific OfficerSSale−1.78K$1.03−$1.83K−6.4%26.1K after2 lots
Nov 10, 2022 (view filing)Nov 9-101 dayO'Kane KieranChief Commercial OfficerSSale−1.71K$1.03−$1.76K−10.1%15.2K after2 lots
Nov 21, 2022 (view filing)Nov 21Same dayKayyem Jon FaizDirectorPPurchase+173.9K$1.15+$200.0KNew position173.9K after
Nov 21, 2022 (view filing)Nov 21Same dayStrobeck MatthewDirectorPPurchase+869.6K$1.15+$1.00M+56.3%2.42M after
Nov 21, 2022 (view filing)Nov 21Same dayStrobeck MatthewDirectorPPurchase+1.80M$1.15+$2.07M+537.2%2.14M after5 lots
Nov 21, 2022 (view filing)Nov 21Same daySchuler Jack WDirector, 10% OwnerPPurchase+8.70M$1.15+$10.0M+77.3%20.0M after
Nov 21, 2022 (view filing)Nov 21Same dayPatience JohnDirector, 10% Owner, Other: ChairmanPPurchase+1.74M$1.15+$2.00M+61.9%4.55M after
Nov 21, 2022 (view filing)Nov 21Same dayWatts Charles MDirectorPPurchase+43.5K$1.15+$50.0K+553.5%51.3K after
Nov 21, 2022 (view filing)Nov 21Same dayMassarany HanyDirectorPPurchase+130.4K$1.15+$150.0K+1,739.1%137.9K after
Dec 14, 2022 (view filing)Dec 122 daysSchuler Jack WDirector, 10% OwnerPPurchase+100.0K$1.48+$148.0K+0.5%20.1M after
Dec 15, 2022 (view filing)Dec 132 daysSchuler Jack WDirector, 10% OwnerPPurchase+67.4K$1.58+$106.5K+0.3%20.1M after
Dec 16, 2022 (view filing)Dec 142 daysSchuler Jack WDirector, 10% OwnerPPurchase+189.7K$1.65+$313.0K+0.9%20.3M after
Dec 20, 2022 (view filing)Dec 164 daysSchuler Jack WDirector, 10% OwnerPPurchase+10.0K$1.70+$17.0K0.0%20.3M after